Related Experiment Video

Updated: Mar 12, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

19.1K

Novel therapeutic strategies for patients with triple-negative breast cancer

Jun-Fei Zhang1, Jia Liu2, Yu Wang2

  • 1Affiliated Hospital of Inner Mongolia University for the Nationalities, Tongliao, Inner Mongolia, People's Republic of China.

Oncotargets and Therapy
|November 2, 2016
PubMed

Insights

Triple-negative breast cancer (TNBC) lacks targeted therapies, with chemotherapy resistance leading to poor outcomes. This review explores emerging targeted agents to improve treatment strategies for this aggressive breast cancer subtype.

Area of Science:

  • Oncology
  • Translational Medicine

Background:

  • Triple-negative breast cancer (TNBC) is a heterogeneous disease with limited therapeutic options.
  • Current standard treatment relies on chemotherapy, often leading to rapid resistance and poor prognosis in metastatic cases.
  • The absence of specific targeted agents necessitates urgent development of novel therapeutic strategies.

Approach:

  • This article reviews recent advancements in targeted agents investigated for TNBC.
  • It focuses on strategies with the potential to overcome chemotherapy resistance.
  • The review aims to inform future personalized therapeutic design and research.

Key Points:

  • TNBC heterogeneity poses challenges for effective treatment.
  • Chemotherapy resistance is a major hurdle in managing TNBC.
  • Emerging targeted agents show promise for overcoming resistance.
  • Personalized therapeutic approaches are crucial for improving outcomes.

Conclusions:

  • Novel targeted agents are critical for advancing TNBC treatment.
  • Future research should focus on developing specific therapeutics for TNBC.
  • Personalized medicine holds potential for improving patient prognosis.
Keywords:
TNBCtargeted agentstherapeutic strategies

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.2K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

4.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K